Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    Search Startups

    Multiple funding stages, Tagged as ('genetic-disorders') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (3)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    11 Startups 1 In the News 2 Recently Updated
    • Total Funding
      $433.5M
      Raised
      20
      Events
    • Private Funding
      $217.8M
      Raised
      14
      Rounds
    • Public Offerings
      $215.7M
      Raised
      6
      Offerings
    • M&A
      $0
      Raised
      0
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Protalix BioTherapeutics logo

    Protalix BioTherapeutics

    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    1994 B2B 51-200 Public $159.9M
    antibodies
    oral-drugs
    pharmaceuticals
    proteins
    genetic-disorders
    plant-protein
    inflammatory-diseases
    pharma-companies
    drug-development
    Eloxx Pharmaceuticals logo

    Eloxx Pharmaceuticals

    Public
    Treatment of Rare Genetic Diseases
    2013 B2B 11-50 Public $98.5M
    rare-diseases
    drug-discovery
    biopharmaceutical
    biotechnology
    therapeutics
    pharmaceuticals
    pharma-companies
    patients
    genetic-disorders
    RNAble logo

    RNAble

    Modulating RNA Epitranscriptomics
    2021 B2B 1-10 Seed Undisclosed
    cancer
    rare-diseases
    pharmaceuticals
    genetic-disorders
    cancer-therapy
    IdentifAI Genetics logo

    IdentifAI Genetics

    Noninvasive Prenatal Testing for Genetic Disorders
    2020 B2B 11-50 Seed $8.25M
    femtech
    pregnancy
    genetics
    machine-learning
    deep-learning
    diagnostics
    artificial-intelligence
    women-health
    biotechnology
    genetic-disorders
    non-invasive
    babies
    blood-test
    early-detection
    healthcare-providers
    women
    pharmaceuticals
    Bioblast Pharma logo

    Bioblast Pharma

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutic Agents for Rare Genetic Diseases
    2012 B2B 1-10 Public $39.75M
    biopharmaceutical
    therapeutics
    neurology
    biotechnology
    drug-discovery
    genetic-disorders
    1E Therapeutics logo

    1E Therapeutics

    Novel RNA-targeting Drugs
    2021 B2B 11-50 Seed $120M
    genetic-disorders
    cancer
    pharmaceuticals
    chronic-disease
    immunology
    viral-diseases
    oncology
    pharma-companies
    drug-development
    therapeutics
    infectious-disease
    Skip Therapeutics logo

    Skip Therapeutics

    RNA-based Therapies for Genetic Disorders
    2021 B2B 1-10 Seed Undisclosed
    pharmaceuticals
    biotechnology
    treatments
    precision-medicine
    bioinformatics
    drug-discovery
    genetic-disorders
    personalization
    rare-diseases

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    11 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $433.5M
      Raised
      20
      Events
    • Private Funding
      $217.8M
      Raised
      14
      Rounds
    • Public Offerings
      $215.7M
      Raised
      6
      Offerings
    • M&A
      $0
      Raised
      0
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Protalix BioTherapeutics logo
    Raised
    $159.9M
    Protalix BioTherapeutics
    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    Founded:1994
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Eloxx Pharmaceuticals logo
    Raised
    $98.5M
    Eloxx Pharmaceuticals
    Public
    Treatment of Rare Genetic Diseases
    Founded:2013
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    RNAble logo
    Raised
    Undisclosed
    RNAble
    Modulating RNA Epitranscriptomics
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    IdentifAI Genetics logo
    Raised
    $8.25M
    IdentifAI Genetics
    Noninvasive Prenatal Testing for Genetic Disorders
    Founded:2020
    Business Model:B2B
    Employees:11-50
    Funding Stage:Seed
    Bioblast Pharma logo
    Raised
    $39.75M
    Bioblast Pharma
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutic Agents for Rare Genetic Diseases
    Founded:2012
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    1E Therapeutics logo
    Raised
    $120M
    1E Therapeutics
    Novel RNA-targeting Drugs
    Founded:2021
    Business Model:B2B
    Employees:11-50
    Funding Stage:Seed
    Skip Therapeutics logo
    Raised
    Undisclosed
    Skip Therapeutics
    RNA-based Therapies for Genetic Disorders
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,